Stock Track | Grifols Shares Soar on Strong Q3 Sales, Earnings Growth

Stock Track

2024/11/08

Shares of Spanish pharmaceuticals company Grifols SA (GRFS) surged 5.16% on Thursday, driven by the company's better-than-expected third-quarter financial results and bullish outlook.

Grifols reported a 12.2% year-over-year increase in total revenue to €1.79 billion ($1.93 billion) for the third quarter, exceeding analysts' expectations. The strong performance was fueled by the company's biopharma division, which saw robust demand for its products.

Additionally, Grifols' adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) rose 26.7% at constant currency to €462 million, benefiting from a favorable product mix, lower costs, and operational leverage. The company remains on track to achieve full-year revenue exceeding €7 billion.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1146633442"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1146633442\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1146633442?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-08 18:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1146633442","market":"us","top_or_hot":-1,"title":"Stock Track | Grifols Shares Soar on Strong Q3 Sales, Earnings Growth","media":"Stock Track","content":"<p>Shares of Spanish pharmaceuticals company Grifols SA (GRFS) surged 5.16% on Thursday, driven by the company's better-than-expected third-quarter financial results and bullish outlook.</p>\n\n<p>Grifols reported a 12.2% year-over-year increase in total revenue to €1.79 billion ($1.93 billion) for the third quarter, exceeding analysts' expectations. The strong performance was fueled by the company's biopharma division, which saw robust demand for its products.</p>\n\n<p>Additionally, Grifols' adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) rose 26.7% at constant currency to €462 million, benefiting from a favorable product mix, lower costs, and operational leverage. The company remains on track to achieve full-year revenue exceeding €7 billion.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Grifols Shares Soar on Strong Q3 Sales, Earnings Growth</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Grifols Shares Soar on Strong Q3 Sales, Earnings Growth\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2024-11-08 18:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Spanish pharmaceuticals company Grifols SA (GRFS) surged 5.16% on Thursday, driven by the company's better-than-expected third-quarter financial results and bullish outlook.</p>\n\n<p>Grifols reported a 12.2% year-over-year increase in total revenue to €1.79 billion ($1.93 billion) for the third quarter, exceeding analysts' expectations. The strong performance was fueled by the company's biopharma division, which saw robust demand for its products.</p>\n\n<p>Additionally, Grifols' adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) rose 26.7% at constant currency to €462 million, benefiting from a favorable product mix, lower costs, and operational leverage. The company remains on track to achieve full-year revenue exceeding €7 billion.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GRFS","symbol_name":"基立福","start_time":0,"source_url":"","article_id":"1146633442","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1146633442","pubTimestamp":1731062657,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Spanish pharmaceuticals company Grifols SA  surged 5.16% on Thursday, driven by the company's better-than-expected third-quarter financial results and bullish outlook.Grifols reported a 12.2% year-over-year increase in total revenue to 1.79 billion  for the third quarter, exceeding analysts' expectations. The strong performance was fueled by the company's biopharma division, which saw robust demand for its products.Additionally, Grifols' adjusted earnings before interest, taxes, deprec","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"GRFS":"基立福"},"translate_title":"股票追踪Grifols股价因第三季度强劲销售和盈利增长而飙升","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GRFS":1},"content_text":"Shares of Spanish pharmaceuticals company Grifols SA (GRFS) surged 5.16% on Thursday, driven by the company's better-than-expected third-quarter financial results and bullish outlook.\nGrifols reported a 12.2% year-over-year increase in total revenue to €1.79 billion ($1.93 billion) for the third quarter, exceeding analysts' expectations. The strong performance was fueled by the company's biopharma division, which saw robust demand for its products.\nAdditionally, Grifols' adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) rose 26.7% at constant currency to €462 million, benefiting from a favorable product mix, lower costs, and operational leverage. The company remains on track to achieve full-year revenue exceeding €7 billion.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}